Page last updated: 2024-09-03

n(6)-carboxymethyllysine and Multiple Sclerosis, Relapsing-Remitting

n(6)-carboxymethyllysine has been researched along with Multiple Sclerosis, Relapsing-Remitting in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bozhinov, A; Daskalovska, V; Genov, K; Handzhiyski, Y; Ivanov, I; Mironova, R; Niwa, T	1

Other Studies

1 other study(ies) available for n(6)-carboxymethyllysine and Multiple Sclerosis, Relapsing-Remitting

Article	Year
Advanced glycation end products contribute to the immunogenicity of IFN-β pharmaceuticals. The Journal of allergy and clinical immunology, 2012, Volume: 129, Issue:3 Topics: Adult; Animals; Antibodies, Neutralizing; CHO Cells; Cricetinae; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Female; Glycation End Products, Advanced; Glycosylation; Haptens; Humans; Imidazoles; Immunotherapy; Interferon-beta; Lysine; Male; Multiple Sclerosis, Relapsing-Remitting; Protein Processing, Post-Translational; Recombinant Proteins	2012

Article

Year

Advanced glycation end products contribute to the immunogenicity of IFN-β pharmaceuticals.

The Journal of allergy and clinical immunology, 2012, Volume: 129, Issue:3

Topics: Adult; Animals; Antibodies, Neutralizing; CHO Cells; Cricetinae; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Female; Glycation End Products, Advanced; Glycosylation; Haptens; Humans; Imidazoles; Immunotherapy; Interferon-beta; Lysine; Male; Multiple Sclerosis, Relapsing-Remitting; Protein Processing, Post-Translational; Recombinant Proteins

2012